Studies have demonstrated that both intracellular overexpression and extracellular forms of PKM2 can enhance cardiac function, reduce infarct scar size, and preserve myocardial structure in various small animal models of MI, HF and IR injury, as well as in large animal models of CVD. Here, PKM is linked to myocardial infarction.